Seattle startup claims India-based drugmaker stole COVID-19 vaccine tech, seeks $950M (Charlotte Schubert/GeekWire)

Charlotte Schubert / GeekWire
Seattle startup claims India-based drugmaker stole COVID-19 vaccine tech, seeks $950M – Seattle vaccine company HDT Bio is seeking nearly $1 billion in a new lawsuit alleging that an India-based drugmaker stole HDTs mRNA COVID-19 vaccine technology. The complaint, filed Monday in federal court in Seattle, asks for at least $950 million in damages from Emcure Pharmaceuticals, and an order banning its …

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to our Newsletter